Bank of New York Mellon’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
PGCM
TCMX
IC
SWM
Bank of New York Mellon's GDRX Position: Q2 2026 in Review
Bank of New York Mellon reduced its GoodRx Holdings (GDRX) stake by 2.1% in Q2 2026, selling an estimated $10.4K and leaving 187,519 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.
Bank of New York Mellon first reported a position in GDRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.62M in Q3 2021. 73 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.
- Bank of New York Mellon held 187,519 shares of GoodRx Holdings worth $540K as of Q2 2026.
- Bank of New York Mellon sold 4,105 GoodRx Holdings shares in Q2 2026, an estimated $10.4K.
- GoodRx Holdings made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3713 holding.
- Bank of New York Mellon first reported a position in GoodRx Holdings in Q4 2020 and has held it in 23 quarters since.
- Bank of New York Mellon's GoodRx Holdings position peaked at $1.62M in Q3 2021.
- 73 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.